𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Intranasal glucagon treatment relieves hypoglycaemia in children with Type 1 (insulin-dependent) diabetes mellitus

✍ Scribed by E. Stenninger; J. Åman


Publisher
Springer
Year
1993
Tongue
English
Weight
549 KB
Volume
36
Category
Article
ISSN
0012-186X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Decreased hepatic glucagon responses in
✍ L. Ørskov; K. G. M. M. Alberti; A. Mengel; N. Møller; O. Pedersen; O. Rasmussen; 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 673 KB

The effect of glucagon infusion on hepatic glucose production during euglycaemia was evaluated in seven Type i (insulin-dependent) diabetic patients and in ten control subjects. In the diabetic subjects normoglycaemia was maintained during the night preceding the study by a variable intravenous insu

Cyclosporin A treatment of young childre
✍ M. Jenner; G. Bradish; C. Stiller; P. Atkison; The London Diabetes Study Group 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 629 KB

Several studies have demonstrated the efficacy of cyclosporin A in modifying the initial course of Type 1 (insulin-dependent) diabetes mellitus in older children and adults but none have reported the effects in very young children. We treated 14 newly-diagnosed Type 1 diabetic patients aged 22 month

Hypoglycaemia and Non-cognitive Aspects
✍ Gold, A.E.; Deary, I.J.; Frier, B.M. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 2 views

## Hypoglycaemia provokes unpleasant symptoms and sensations in patients with insulindependent (Type 1) diabetes mellitus (IDDM). There is much interest in, and information on, the cognitive effects of acute insulin-induced hypoglycaemia. However, the effects of hypoglycaemia on brain function ext

Prevention or delay of Type 1 (insulin-d
✍ R. B. Elliott; H. P. Chase 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 357 KB

A controlled trial of oral nicotinamide to prevent the onset of diabetes mellitus in high risk children was conducted in two centres. The selection criteria were age less than 16 years, islet cell antibody > 80 IUs, and first phase insulin release < 5th percentile. All of eight untreated control sub